Alexandria Real Estate Equities, Inc 8-K, filed Jun 22, 2006
Alexandria Real Estate Equities, Inc. (ARE)
About this 8-K
Alexandria Real Estate Equities, Inc filed this 8-K on June 22, 2006, reporting on events of June 20, 2006.
Items reported
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 20, 2006
ALEXANDRIA REAL ESTATE EQUITIES, INC.
(Exact name of registrant as specified in its charter)
|
Maryland |
|
1-12993 |
|
95-4502084 |
|
(State or other jurisdiction |
|
(Commission |
|
(I.R.S. Employer |
|
of incorporation) |
|
File Number) |
|
Identification No.) |
|
385 E. Colorado Boulevard, Suite 299 |
|
91101 |
||
|
Pasadena, California |
|
(Zip Code) |
||
|
(Address of principal executive offices) |
|
|
||
Registrant’s telephone number, including area code: (626) 578-0777
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR 240.13e-4 (c))
Item 8.01 Other Events
On June 20, 2006, the underwriters of Alexandria Real Estate Equities, Inc.’s recent follow-on public offering of 3,300,000 shares of common stock exercised their overallotment option to purchase an additional 495,000 shares of common stock at a price of $84.00 per share. The closing of the over-allotment option is scheduled for June 23, 2006.
The press release announcing the transaction is attached hereto as Exhibit 99.1 and is filed herewith.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
99.1 Press Release dated June 21, 2006.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
ALEXANDRIA REAL ESTATE EQUITIES, INC. |
|||
|
Date: June 22, 2006 |
|
By: |
|
/s/ Dean A. Shigenaga |
|
|
|
|
|
Dean A. Shigenaga |
|
|
|
|
|
Chief Financial Officer |
3
EXHIBIT 99.1
For Immediate Release
|
Contact: |
|
Joel S. Marcus |
|
|
|
Chief Executive Officer |
|
|
|
Alexandria Real Estate Equities, Inc. |
|
|
|
(626) 578-9693 |
ALEXANDRIA REAL ESTATE EQUITIES, INC.
REPORTS EXERCISE OF OVER-ALLOTMENT OPTION BY UNDERWRITERS
PASADENA, CA. — June 21, 2006 - Alexandria Real Estate Equities, Inc. (NYSE:ARE) announced today that the underwriters of its recent follow-on public offering of 3,300,000 shares of common stock have exercised their over-allotment option to purchase an additional 495,000 shares of common stock at a price of $84.00 per share, bringing the total net proceeds to approximately $304.4 million, after payment of underwriting discounts and commissions. The closing of the over-allotment option is scheduled for June 23, 2006.
Merrill Lynch, Pierce, Fenner & Smith Incorporated and Citigroup Global Markets Inc. acted as joint book- running managers of the offering.
Alexandria Real Estate Equities, Inc. is a publicly-traded real estate investment trust focused principally on the ownership, operation, management, acquisition and selective redevelopment and development of properties containing office/laboratory space. Such properties are designed and improved for lease primarily to institutional (universities and independent not-for-profit institutions), pharmaceutical, biotechnology, medical device, life science product, service, biodefense and translational research entities, as well as government agencies. The Company’s portfolio currently consists of 139 properties comprising approximately 9.2 million square feet of office/laboratory space.
This press release contains forward-looking statements within the meaning of the federal securities laws. The Company’s actual results might differ materially from those projected in the forward-looking statements. Additional information concerning factors that could cause actual results to differ materially from those in the forward-looking statements is contained in the Company’s Annual Report on Form 10-K and its other periodic reports filed with the Securities and Exchange Commission.
This communication shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction. A copy of the prospectus relating to these securities may be obtained, when available, from Merrill Lynch, Pierce, Fenner & Smith Incorporated, 4 World Financial Center, New York, NY 10080, or Citigroup Global Markets Inc., 390 Greenwich Street, New York, New York 10013.
# # #